Clinical Trial Update: A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects

View source ↗

Summary

This is a completed Scandinavian non-interventional study assessing adherence to Rebif administered with the RebiSmart auto-injector in relapsing-remitting mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Rebif (interferon beta-1a)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Relapsing Remitting Multiple Sclerosis (RRMS) | Status: COMPLETED